Showing results (91-100 of 111) with videos related to
Sort By:
Pageof 12
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|November 3, 2012
Olmesartan medoxomil-based antihypertensive therapy evaluated by ambulatory blood pressure monitoring: efficacy in high-risk patient subgroupsSteven G Chrysant, F Wilford Germino, Joel M NeutelCurrent Clinical Pharmacology|February 17, 2010
The treatment of cardiovascular disease continuum: focus on prevention and RAS blockadeSteven G Chrysant, George S Chrysant, Catherine Chrysant, et al.Clinical Therapeutics|May 24, 2008
The combination of olmesartan medoxomil and amlodipine besylate in controlling high blood pressure: COACH, a randomized, double-blind, placebo-controlled, 8-week factorial efficacy and safety studySteven G Chrysant, Michael Melino, Sulekha Karki, et al.Hypertension Research : Official Journal of the Japanese Society of Hypertension|December 13, 2005
Telmisartan/Hydrochlorothiazide in comparison with losartan/hydrochlorothiazide in managing patients with mild-to-moderate hypertensionJoel M Neutel, Thomas W Littlejohn, Steven G Chrysant, et al.American Journal of Hypertension|March 6, 2004
Evaluation of antihypertensive therapy with the combination of olmesartan medoxomil and hydrochlorothiazideSteven G Chrysant, Michael A Weber, Antonia C Wang, et al.Journal of Clinical Hypertension (Greenwich, Conn.)|September 16, 2009
Efficacy and safety of long-term treatment with the combination of amlodipine besylate and olmesartan medoxomil in patients with hypertensionSteven G Chrysant, Suzanne Oparil, Michael Melino, et al.Integrated Blood Pressure Control|August 1, 2013
The TRINITY Study: distribution of systolic blood pressure reductionsDanny H Sugimoto, Steven G Chrysant, Michael Melino, et al.Blood Pressure Monitoring|January 18, 2008
Effects of the angiotensin II receptor blockers telmisartan versus valsartan in combination with hydrochlorothiazide: a large, confirmatory trialWilliam B White, Debra Murwin, Steven G Chrysant, et al.Journal of Clinical Hypertension (Greenwich, Conn.)|January 6, 2009
Results of an olmesartan medoxomil-based treatment regimen in hypertensive patientsSuzanne Oparil, Steven G Chrysant, Dean Kereiakes, et al.Journal of Hypertension|December 5, 2006
Renin inhibition with aliskiren provides additive antihypertensive efficacy when used in combination with hydrochlorothiazideAlberto Villamil, Steven G Chrysant, David Calhoun, et al.Pageof 12